Mi SciELO
Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Citado por Google
- Similares en SciELO
- Similares en Google
Compartir
Hospital a Domicilio
versión On-line ISSN 2530-5115
Resumen
FUENTES MERLOS, Álvaro y LOPEZ-BAS VALERO, Rafael. Pharmacological management of malignant bowel obstruction. Hosp. domic. [online]. 2020, vol.4, n.2, pp.81-87. Epub 01-Jun-2020. ISSN 2530-5115. https://dx.doi.org/10.22585/hospdomic.v4i2.102.
Malignant bowel obstruction (MBI) is one of the most difficult problems to manage by palliative care units because of the high burden of often recurrent and sometimes refractory symptoms among patients with advanced cancer. The lack of robust studies means that MBI is managed empirically, with high clinical variability and lack of consensus. We present the clinical case of a patient in charge of the Home Hospitalization Unit who presented a picture of small bowel occlusion due to mesenteric implant in the lower right quadrant. A combination of propellant and antisecretory agents were used, which acted synergistically to reduce gastrointestinal symptoms, and showed an improvement in both quality of life and average survival time.
Palabras clave : Intestinal Obstruction; Abdominal Neoplasms; Drug Therapy; Palliative Care.